CAMPCAMP4 Therapeutics Corporation

$126M

Q1 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$86M+21.6% YoY

Gross Profit

$36M41.6% margin

Operating Income

-$2M-2.7% margin

Net Income

-$3M-4.0% margin

EPS (Diluted)

$-0.10

QoQ Revenue Growth

+3.3%

Cash Flow

Operating Cash Flow

$6M

Free Cash Flow

$4M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$408M

Total Liabilities

$244M

Stockholders' Equity

$164M

Cash & Equivalents

$94M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$86M	$71M	+21.6%
Gross Profit	$36M	$28M	+29.9%
Operating Income	-$2M	$5M	-151.2%
Net Income	-$3M	$6M	-163.3%

Revenue Segments

Wireless Datacom

$86M100%

CAMP Q1 2017 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena